Clinical Trials Browser

Neoplasm Metastasis, Prostatic Neoplasms

NCT03924466 2024-02-16

VUBAR

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Clinical Trials

DART

VUBAR

SAVE

ANZUP2001

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Trace-II

A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer

esSBRT

Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer

The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation

Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer

Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma

PROspect

Unicorn

ImmunoProst

CABA-V7

Administration of Antibiotic Prophylaxis for Transperineal Prostate Biopsy in Cipto Mangunkusumo Hospital

The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate

QRT-SOGUG

Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer

uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness

PEM-PRO

BRAchySABR

Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

PBS

177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer

Cardiovascular Events in GnRH Agonist vs. Antagonist

Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study

Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

PIVOTAL

Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer

A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

ENZART

CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy

Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)

CyberKnife Radiosurgery for Locally Recurrent Prostate CA

CyberKnife Radiosurgery for Localized Prostatic Carcinoma

SPARK

Mansmed

EFFECT